Bridging Depression and Addiction: From Self-Medication to Resilience – Key Insights from GAP 2026

 The upcoming Global Conference on Addiction and Psychiatry (GAP 2026) will feature an insightful presentation by Dr. Eva Ein-Eli, highlighting the complex relationship between depression and substance use disorders (SUDs). This session brings together neuroscience, psychology, and clinical expertise to offer practical, real-world solutions.

Title: Depression and substance use disorders: From self medication to resilience integrating clinical practice and neuroscientific insights

🔍 Key Highlights of the Presentation

  • High Comorbidity & Clinical Burden
    • Strong overlap between depression and substance use disorders
    • Increased suicide risk and poorer treatment outcomes
  • Self-Medication Hypothesis
    • Substance use as a coping mechanism for emotional pain
    • Addiction linked to attempts at managing anxiety, trauma, and distress
  • Neuroscientific Mechanisms
    • Dysregulated dopamine reward system
    • Overactive stress response (HPA axis) driving craving and anhedonia
  • Psychosocial Factors
    • Impact of early trauma, social anxiety, and emotional dysregulation
    • Substance use as compensation for unmet emotional needs
  • Clinical Case Insight
    • Case of Mr. B.L.: progression from recreational use to chronic depression
    • Highlights importance of early, integrated intervention
  • Integrative Treatment Approaches
    • Cognitive Behavioral Therapy (CBT)
    • Motivational Interviewing (MI)
    • Acceptance and Commitment Therapy (ACT)
    • Focus on restoring meaning, control, and resilience
  • Evidence-Based Clinical Recommendations
    • Early dual-diagnosis screening
    • Personalized psychosocial interventions
    • Suicide risk monitoring in addiction care
    • Mindfulness and acceptance-based strategies
    • Community reintegration and stigma reduction
  • Multidisciplinary & Global Approach
    • Collaboration between addiction specialists and mental health professionals
    • Bridging research with clinical practice


🎯 Audience Takeaways

  • Understand the neurobiological and psychological links between depression and addiction
  • Identify early warning signs and risk factors
  • Apply CBT, MI, and ACT in clinical settings
  • Strengthen resilience and long-term recovery strategies
  • Promote global collaboration in mental health care

🌍 Event Details

🔗 Important Links


#GAP2026 #AddictionConference #MentalHealthAwareness #DepressionAndAddiction #DualDiagnosis #NeuroscienceInsights #Psychiatry #CBT #ACT #MotivationalInterviewing #ResilienceBuilding #TraumaInformedCare #SubstanceUseDisorder #GlobalHealth #Mindfulness #EmotionalWellbeing

Comments

Post a Comment

Popular posts from this blog

First Round Call for Abstracts & Early Registration – GAP 2026

Image
The Global Conference on Addiction and Psychiatry (GAP 2026) invites researchers, clinicians, and professionals to participate in this prestigious international event, taking place August 24–26, 2026 at the Sheraton Skyline Hotel London Heathrow, United Kingdom . Important Deadlines: First Round Abstract Submission Ends: April 29, 2026 Early Registration Closes: April 30, 2026 This is your opportunity to contribute to meaningful discussions and showcase your research on a global stage. Why Attend GAP 2026? Present innovative research in addiction and psychiatry Network with international experts and peers Gain insights into the latest advancements in mental health Important Links: Abstract Submission: https://addiction.irisscientificgroup.com/abstract-submission Registration: https://addiction.irisscientificgroup.com/register Conference Website: https://addiction.irisscientificgroup.com/ ⏳ With deadlines fast approaching, we encourage all interested participants to act now and secu...
Read more

🚨 First Round Abstract Submissions Are Now Open for GAP 2026! 🚨

Image
The wait is over! The Global Conference on Addiction and Psychiatry (GAP 2026) is now officially accepting first round abstract submissions for its upcoming prestigious hybrid conference happening on August 24–26, 2026 , at the Sheraton Skyline Hotel London Heathrow, London, UK , with virtual participation options available worldwide. This is your opportunity to showcase your latest research, clinical findings, innovations, and case studies before leading global experts in psychiatry, addiction medicine, neuroscience, behavioral health, and recovery science . 📢 Abstract slots are filling fast! With the conference approaching and the first round submission deadline closing on April 15, 2026 , this is the best time to submit early, secure your presentation slot, and confirm your participation . 🎯 Whether you are a researcher, clinician, academician, psychologist, psychiatrist, or healthcare professional, now is the perfect time to reserve your place in the scientific program. ✅ Submi...
Read more

🧠 Abstract Submissions Closing Soon – Final Call for GAP 2026!

Image
 The countdown has begun for the Global Conference on Addiction and Psychiatry (GAP 2026) , and this is your last opportunity to submit your abstract and secure your presentation slot before the conference begins. 📅 Conference Dates: August 24–26, 2026 📍 Conference Venue: Sheraton Skyline Hotel London Heathrow, Heathrow Airport, Bath Rd, London, United Kingdom UB3 5BP 🌐 Mode: Hybrid (In-person & Online) As a leading international platform in psychiatry, addiction medicine, behavioral science, recovery research, and mental health innovation , GAP 2026 will unite psychiatrists, psychologists, addiction specialists, neuroscientists, therapists, counselors, and healthcare researchers from around the world. This is your opportunity to showcase your latest work in substance use disorders, relapse prevention, behavioral therapies, neuropsychiatry, trauma care, digital mental health, recovery science, and psychiatric innovations . 👉 Submit your abstract now:  https://addi...
Read more